Target intelligence / Profile preview

Small nucleolar RNA SNORD39 (SNORD39)

Target
SNORD39
Molecular classification
Non-coding RNA, Box C/D small nucleolar RNA (SNORD), Small nucleolar RNA
01

Overview

Small nucleolar RNA SNORD39 (also known as snoRNA U39, SNORD55, or U55) is a non-coding RNA molecule found in the nucleolus of eukaryotic cells[2]. It belongs to the C/D box class of small nucleolar RNAs, which are characterized by conserved sequence motifs called the C box (UGAUGA) and the D box (CUGA)[2][1][3][4]. SNORD39 functions as a guide RNA: it directs site-specific 2'-O-methylation of substrate RNAs, particularly the 28S ribosomal RNA at position C2791[2]. C/D box snoRNAs like SNORD39 are essential components of small nucleolar ribonucleoprotein complexes (snoRNPs), along with core proteins such as fibrillarin, Nop56, Nop58, and Snu13, and are primarily involved in post-transcriptional modification and maturation of rRNAs and sometimes small nuclear RNAs (snRNAs)[1][3][5]. While several snoRNAs have emerging connections to disease (particularly cancer), SNORD39 itself is primarily defined and studied for its canonical role in rRNA modification, and there is currently no evidence in major databases or recent literature to indicate it functions directly as a drug target, biomarker, or has direct disease associations[2][4].

Other names
snoRNA U39SNORD55snoRNA U55LOC124900282
02

Biological functions

2'-O-methylation of ribosomal RNARNA modification guideRibosomal RNA processing
03

Disease associations

Other (some snoRNAs are implicated in disease, but no specific role for SNORD39 is reported)

Beyond the preview

Go deeper on Small nucleolar RNA SNORD39 (SNORD39).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Small nucleolar RNA SNORD39 (SNORD39).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call